Zamboni is expected to say the ‘Tanner study — which was not submitted to the FDA until 2019 — provides evidence that GSK ...

Shares in GSK fell around 9% this morning after ... of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial. Judge Vivian Medinilla of Delaware Superior Court issued an ...

GSK plc (LSE/NYSE: GSK), a leading global pharmaceutical company, has reached a confidential settlement in a Zantac (ranitidine ... SWIFT-2 phase III clinical trials. However, the company ...

Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 ...

(Sharecast News) - GSK announced on Wednesday that it has reached confidential settlements in two lawsuits filed in California State Court related to its discontinued heartburn medication, 'Zantac ...

"They say in the trial, 'All you need to know is the science and we win,' and that argument ... which will be the first Zantac trials in California." GlaxoSmithKline didn't admit liability ...

The case, brought by Illinois resident Ronald Kimbrow, alleged that Zantac caused his prostate cancer after he took the drug from 1995 to 2019. The sole defendant in the trial was German drugmaker ...